Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 250 of 643 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 12/31/05
End: 07/31/08
Due: 07/31/09
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 06/30/22
Due: 06/30/23
Phase: N/A
Priority: Normal
Start: 04/30/23
End: 04/30/23
Due: 04/30/24
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 04/12/24
Due: 04/12/25
Phase: N/A
Priority: Normal
Start: 05/01/16
End: 08/17/21
Due: 08/17/22
Phase: N/A
Priority: Normal
Start: 08/12/19
End: 06/15/23
Due: 06/15/24
Phase: N/A
Priority: Normal
Start: 03/23/20
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 11/27/23
End: 07/01/24
Due: 07/01/25
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 03/17/17
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 06/15/21
Due: 06/15/22
Phase: N/A
Priority: Normal
Start: 08/26/19
End: 03/03/25
Due: 03/03/26
Phase: N/A
Priority: Normal
Start: 03/03/15
End: 05/14/20
Due: 05/14/21
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 08/28/20
End: 09/30/22
Due: 09/30/23
Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 08/31/11
Due: 08/31/12